Blanchet, Lionel
Smeitink, Jan A. M.
van Emst - de Vries, Sjenet E.
Vogels, Caroline
Pellegrini, Mina
Jonckheere, An I.
Rodenburg, Richard J. T.
Buydens, Lutgarde M. C.
Beyrath, Julien
Willems, Peter H. G. M.
Koopman, Werner J. H.
Article History
Received: 21 August 2014
Accepted: 22 December 2014
First Online: 26 January 2015
Competing interests
: This research was supported by the CSBR (Centres for Systems Biology Research) initiative from the Netherlands Organisation for Scientific Research (NWO; No: CSBR09/013V) and a PM-Rare (Priority Medicines Rare disorders and orphan diseases) grant from ZON-MW (Netherlands Organization for Health Research and Development-Medical Sciences, No: 40-41900-98-033), the Energy4All foundation (ExternalRef removed), the TIM foundation (ExternalRef removed) and an equipment grant of NWO (Netherlands Organization for Scientific Research, No: 911-02-008). Part of this research was carried out at the SME Khondrion BV. LB, JS, SvE, CV, MP, JB, PW and WK are (fully or partly) employed by Khondrion BV. AJ, RR and Pr. LMCB declare no potential conflict of interest. The four newly generated antioxidants described in this study are covered by a patent (Int. patent appl. no. PCT/NL2013/050528).